Karyopharm Therapeutics, Inc. (KPTI)
1.755
-0.04
(-1.96%)
USD |
NASDAQ |
Sep 03, 16:00
1.755
0.00 (0.00%)
After-Hours: 19:22
Karyopharm Therapeutics Cash from Investing (Quarterly) : -10.04M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.04M |
| March 31, 2026 | 3.20M |
| December 31, 2025 | 5.00M |
| September 30, 2025 | 4.805M |
| June 30, 2025 | 18.28M |
| March 31, 2025 | 15.29M |
| December 31, 2024 | 14.80M |
| September 30, 2024 | 7.474M |
| June 30, 2024 | 51.26M |
| March 31, 2024 | 21.94M |
| December 31, 2023 | 26.84M |
| September 30, 2023 | -7.685M |
| June 30, 2023 | 21.17M |
| March 31, 2023 | -32.39M |
| December 31, 2022 | -65.30M |
| September 30, 2022 | 11.67M |
| June 30, 2022 | -36.60M |
| March 31, 2022 | -14.04M |
| December 31, 2021 | 30.77M |
| September 30, 2021 | 21.43M |
| June 30, 2021 | 46.46M |
| March 31, 2021 | 43.19M |
| December 31, 2020 | 31.40M |
| September 30, 2020 | 21.43M |
| June 30, 2020 | -60.03M |
| Date | Value |
|---|---|
| March 31, 2020 | -46.48M |
| December 31, 2019 | -33.52M |
| September 30, 2019 | 40.18M |
| June 30, 2019 | 39.80M |
| March 31, 2019 | 31.99M |
| December 31, 2018 | -103.11M |
| September 30, 2018 | 20.57M |
| June 30, 2018 | -27.60M |
| March 31, 2018 | 2.484M |
| December 31, 2017 | -2.901M |
| September 30, 2017 | 20.59M |
| June 30, 2017 | -1.134M |
| March 31, 2017 | 0.549M |
| December 31, 2016 | 6.602M |
| September 30, 2016 | -4.975M |
| June 30, 2016 | 16.22M |
| March 31, 2016 | 6.751M |
| December 31, 2015 | 33.84M |
| September 30, 2015 | 44.56M |
| June 30, 2015 | 0.858M |
| March 31, 2015 | -170.08M |
| December 31, 2014 | -63.90M |
| September 30, 2014 | -2.286M |
| June 30, 2014 | -0.324M |
| March 31, 2014 | -0.525M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 34.20M |
| Relay Therapeutics, Inc. | -353.03M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -24.93M |
| Cash from Financing (Quarterly) | -0.898M |
| Free Cash Flow | -65.35M |
| Free Cash Flow Per Share (Quarterly) | -0.8615 |
| Free Cash Flow to Equity (Quarterly) | -50.25M |
| Free Cash Flow to Firm (Quarterly) | -11.79M |
| Free Cash Flow Yield | -185.6% |